292: The Fool's Game That Became Standard Practice: Perfusion, the ATF, and What Changed with John Bonham-Carter - Part 2

Biotech founders often pour everything into building the “perfect” product only to realize their real customers have walked out the door. Chasing perfection can burn money and stall even the most promising CMC innovations.
In this episode, David Brühlmann continues his conversation with biotech entrepreneur and investor John Bonham-Carter. John shares his insights on the realities of building and scaling successful biotools companies, from the challenges of fundraising and the importance of authentic storytelling, to knowing when to stop perfecting a product and start selling.
Topics discussed:
• How fundraising is less about money and more about the story, team, and real commitment behind a startup (02:33)
• Practical advice for founders: obsess over the customer, not just the technology (07:14)
• The dangers of spreading yourself too thin as a startup founder and lessons from parenting applied to startups (07:09)
• Choosing business partners and collaborators whose skills complement your own—and making peace with imperfection (10:10)
• John’s approach to building teams and why accepting mediocrity in some areas can lead to collective excellence (11:16)
• The story behind John joining Stellion Biosystems, and what makes their cell counting technology different in the market (11:51)
• Using creative, low-budget tactics for visibility—why John chose a lizard mascot for Stellion Biosystems (15:19)
• Thoughts on when (if ever) to stop and the value of keeping multiple life and career doors open (17:26)
• John’s main takeaway: “Try everything”—professional advice drawn from experience (and Zootopia) (19:01)
Smart insight: John leaves us with a simple yet powerful credo: “Try everything.” In biotech, that means embracing experimentation not just in the lab, but in business strategy, partnerships, hiring, and technology adoption. By collaborating, iterating, and listening closely to customers, you can grow, succeed, and—perhaps—build something that truly makes a difference. In a field where the only constant is change, remember: launch before you’re ready, find your people, and keep your story genuine.
Some ideas are ahead of their time; a few people make a career of being early. This is part bioprocess history, part founder's playbook: why the best technology doesn't automatically win, how to move a conservative industry, and when to sell rather than scale. To go further on both the technology and the business behind it:
• Episodes 191 - 192: Process Intensification Secrets: A Process Engineer's Decision Framework with Andreas Castan
• Episodes 183 - 184: From Lab to Market: Secrets to Commercializing Cutting-Edge Biotech Innovations with Chervee Ho
• Episodes 259 - 260: Why Strong Science Isn't Enough to Get Funded: What Investors Actually Look For with Michael Rome
• Episodes 165 - 166: Why Your Funding Pitches Fail Despite Brilliant Science (And How to Fix It)
Connect with John Bonham-Carter:
Website: stellion-biosystems.com
LinkedIn: linkedin.com/in/johnbc
Free 5-day email course, The CMC Failure Chain: the five recurring CMC mistakes that put your promising program at risk → Get it here (smartbiotechscientist.com/#cmc)
Support the show (buzzsprout.com/2263581/support)